Drug-Induced Liver Injury (DILI): Recognition & Prevention

Upon completion of this course, learners will be able to:

1. Define Drug-Induced Liver Injury (DILI) and understand its clinical significance.

2. Identify medications and supplements commonly associated with hepatotoxicity.

3. Recognize early and late clinical manifestations of DILI.

4. Implement monitoring strategies, including laboratory tests and imaging studies.

5. Educate patients about hepatotoxic risks and preventive measures.

6. Apply evidence-based interventions to prevent progression and complications.

7. Collaborate with interdisciplinary teams, including pharmacists and hepatologists, for optimal patient outcomes.

8. Manage DILI cases using pharmacologic and non-pharmacologic strategies